Evaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatment
View/
Access
info:eu-repo/semantics/openAccessAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Date
2023Metadata
Show full item recordCitation
Çinpolat, H.Y., Alkan, S., Altınışık, H.B., Ülker Çakır, D., & Oğuzman, H. (2023). Evaluation of Serum Creatinine Levels with Reference Change Value in Patients Receiving Colistin Treatment. Labmedicine. https://doi.org/10.1093/labmed/lmad009 Abstract
Objective
In this study, we aimed to evaluate the serum creatinine (SCr) levels with the reference change value (RCV) in patients receiving colistin treatment.
Methods
We retrospectively recorded the SCr levels of 47 patients receiving colistin treatment before treatment and on days 3 and 7 after treatment. RCV was calculated with the asymmetrical RCV formula (Z = 1.64, P < .05). Percent (%) increase in the SCr results of the patients was compared with RCV and values exceeding RCV were regarded as statistically significant.
Results
The RCV was calculated as 15.6% for SCr. Compared with pretreatment values, SCr value on day 3 was 32/47 and on day 7 it was 36/47; as these results exceeded RCV, they were considered statistically significant.
Conclusion
Use of RCV in the interpretation of results between serial measurements will provide a more rapid and sensitive method when making decisions.
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as info:eu-repo/semantics/openAccess
